NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for USA stock FATE Fate Therapeutics. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 2.13 and Closed at: 2.08, which is -4.33% of previous session's close. It moved within a range of 2.01 and 2.16
The session was a Bearish session with an average volume of 1064400, which is 24.45% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 1.97 and resistance for tomorrow is 2.12
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.01, 1.93 resistance for tomorrow's hourly charts is 2.16, 2.23

10 Day SMA for Fate Therapeutics (FATE) is 2.08 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Fate Therapeutics (FATE) is 2.09 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Fate Therapeutics (FATE) is 2.29 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 2.42 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Fate Therapeutics is 1.97 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Fate Therapeutics is at 2.09 and 200 DMA is at 1.97, while 50 DMA and 100 DMA are at 2.29 and 2.42 respectively

Fate Therapeutics (FATE) moving average of 20 SMA is at 2.09 and 20 EMA is at 2.12

Fate Therapeutics (FATE) moving average of 50 SMA is at 2.29 and 50 EMA is at 2.22

Fate Therapeutics (FATE) moving average of 100 SMA is at 2.42 and 100 EMA is at 2.25

Fate Therapeutics (FATE) moving average of 200 SMA is at 1.97 and 200 EMA is at 2.02

Penumbra Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Penumbra Inc, about 14.98% more returns!

Prestige Consumer has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Prestige Consumer, about 21.99% more returns!

Iqvia Holdings has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Iqvia Holdings, about 14.87% more returns!

Hca Healthcare has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Hca Healthcare, about 23.2% more returns!

Fresenius Medical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Fresenius Medical, about 13.61% more returns!

Fate Therapeutics has performed better than Vanda Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

Radnet Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Radnet Inc, about 18.54% more returns!

Protagonist Therapeutics has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 17.4% more returns!

Fate Therapeutics has performed better than Organogenesis Holdings in short term. Holding Fate Therapeutics could be a better choice for now!

Natera Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Natera Inc, about 11.73% more returns!

Fate Therapeutics has performed better than Medicinova Inc in short term. Holding Fate Therapeutics could be a better choice for now!

Innoviva Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Innoviva Inc, about 17.21% more returns!

Fate Therapeutics has performed better than Immuron in short term. Holding Fate Therapeutics could be a better choice for now!

Icon Plc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 39.96% more returns!

Henry Schein has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Henry Schein, about 15.17% more returns!

Genesis Healthcare has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Genesis Healthcare, about 45.15% more returns!

Equillium Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Equillium Inc, about 8.88% more returns!

Biomarin Pharmaceutical has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Biomarin Pharmaceutical, about 16.09% more returns!

Fate Therapeutics Technical analysis of indicators

Price action analysis of Fate Therapeutics (FATE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Fate Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Fate Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Fate Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Fate Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.06 and Fate Therapeutics FATE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

Fate Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And FATE Experts View which covers a lot of information including buying and selling signals

FATE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet